Serentrix Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Serentrix General Information

Description

Developer of targeted small molecule therapies designed for innocuous pain relief without the risk of addiction. The company focuses on an approach that utilizes specially designed molecules to target specific pain pathways in the body, enabling clinicians and patients to have effective pain management without the addictive properties often associated with traditional pain medications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1 East Uwchlan Avenue
  • Suite 301
  • Exton, PA 19341
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 1 East Uwchlan Avenue
  • Suite 301
  • Exton, PA 19341
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Serentrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 13-Sep-2023 Completed Clinical Trials - Phase 1
1. Accelerator/Incubator 18-Feb-2022 Completed Clinical Trials - Phase 1
To view Serentrix’s complete valuation and funding history, request access »

Serentrix Patents

Serentrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2552888-A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion" Active 30-Mar-2010
EP-2552888-B1 Trpv1 vanilloid receptor antagonists with a bicyclic portion Active 30-Mar-2010
US-10233177-B2 Trpv1 vanilloid receptor antagonists with a bicyclic portion Active 30-Mar-2010
US-20130079339-A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion Active 30-Mar-2010
US-20160289199-A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion Inactive 30-Mar-2010 C07D413/14
To view Serentrix’s complete patent history, request access »

Serentrix Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Innovation Space Accelerator/Incubator
PitchHU Accelerator/Incubator
To view Serentrix’s complete investors history, request access »

Serentrix FAQs

  • When was Serentrix founded?

    Serentrix was founded in 2014.

  • Where is Serentrix headquartered?

    Serentrix is headquartered in Exton, PA.

  • What industry is Serentrix in?

    Serentrix’s primary industry is Drug Discovery.

  • Is Serentrix a private or public company?

    Serentrix is a Private company.

  • What is Serentrix’s current revenue?

    The current revenue for Serentrix is .

  • Who are Serentrix’s investors?

    The Innovation Space and PitchHU have invested in Serentrix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process